학술논문
Continued indinavir (800 mg tid) versus switching to indinavir plus ritonavir (800/100 mg bid) in HIV patients having achieved viral load suppression. A randomized study: the BID efficacy and safety trial (BEST)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
02699370